PATENT CLAIM ANALYSIS

Application Number: 15950443
Application Type: Utility
Filing Date: 2018-04
Publication Date: 2018-08
Patent Classification: ["544", "236000"]

Abstract:
The invention concerns compounds of Formula (I) or pharmaceutically-acceptable salts thereof, wherein R 1 , R 2  and n have any of the meanings defined hereinbefore in the description; processes for their preparation, pharmaceutical compositions containing them and their use as anti-proliferative and/or cell-killing agents.

Claim (Index 9):
A method for the prevention or treatment of cancer in a warm blooded animal such as man in need of such treatment which comprises administering to said animal an effective amount of a co-crystal of (R)-4-(2-(4-(1-(3-methoxy-[1,2,4]triazolo[4,3-b]pyridazin-6-yl)piperidin-4-yl)phenoxy)ethyl)-1,3-dimethylpiperazin-2-one and the co-former molecule 6-hydroxy-2-naphthoic acid.

Metadata:
- Claim Count in Document: 1.0
- Percentile: 91.0
- Lexical Diversity: 1.15909
- Patent Class: 544.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15329274', '14282515', '15037116', '14892623', '14575284']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8169671364282128
- 35 USC 102 Novelty (BERT): 0.5819602651621213
- Combined Prediction Score: 0.7934664493016037
- Mean Citation Score: 378.181022
- Max Citation Score: 563.9356
- Similarity Product: 389.1186886813164

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test